India Launches Global Study on Ayurveda TB Integration

On 24th March 2026, marking World Tuberculosis Day, India launched a first-of-its-kind global clinical study to evaluate the integration of Ayurveda with standard tuberculosis treatment.

Key Points

bjective: To assess Ayurveda as an adjunct to standard Anti-Tuberculosis Treatment (ATT) for improved recovery and patient outcomes.
Scale of Study:
- Over 1,200 patients involved.
- Will be conducted across leading institutions in India.
Focus Areas:
- Nutritional recovery and weight gain
- Disease progression
- Quality of life
- Safety and treatment tolerability
Holistic Approach: Combines modern biotechnology with traditional knowledge to provide patient-centric, comprehensive care.
India’s Progress in TB Control:
- 21% decline in TB incidence since 2015.
- Cases reduced to ~187 per 100,000 population (2024).
- Driven by the National TB Elimination Programme.
Key Challenges Addressed:
- Drug resistance
- Treatment toxicity
- Undernutrition
- Linkages with diseases like diabetes